Repurposing of Drugs: Updates and New Perspectives

Author:

R. Aher Pratik1,V. Aher Rushikesh1,S. Ahire Tejas1,B. Patil Monali1,V. Shahare Hitesh1,S. Gedam Shweta2

Affiliation:

1. SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, Maharashtra – 423101.

2. Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India.

Abstract

Drug repurposing is an innovative drug discovery technique that looks for new therapeutic advantages in previously used, shelved, and clinically tested medications. This strategy is now gaining traction as a way to get around the financial, timing, and resource bottlenecks that plague traditional drug development. Several efforts have been undertaken in this respect to develop stratagems based on bioinformatics and computational technologies to speed up the repurposing process. A number of novel computational tools have evolved to enable systematic repurposing screenings, both experimentally and through in silico techniques. Access to molecular data, adequate analytical knowledge to provide strong insights, knowledge and experimental set up for validation, and clinical development know-how are all required for a successful medication repurposing pipeline. This review presents the benefits, considerations, and obstacles in repurposing as a drug development strategy adopted by pharmaceutical companies.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3